Family and Caregiver Schizophrenia Discussion Forum

Patch to reduce hostility among patients with schizophrenia

The antipsychotic “patch” effectively reduced hostility among patients with schizophrenia, a researcher reported.

In a post-hoc analysis of a phase III trial, once-daily asenapine transdermal system (Secuado) – the first transdermal patch FDA-approved for schizophrenia – was superior to placebo in reducing symptoms of hostility related to schizophrenia, reported Leslie Citrome, MD, MPH, of New York Medical College in Valhalla.

Antipsychotic Patch Quiets Schizophrenia-Related Hostility